| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOLOGICALS.2010.12.001 |
| P698 | PubMed publication ID | 21277791 |
| P2093 | author name string | Coenraad Hendriksen | |
| Marlies Halder | |||
| Keith Redhead | |||
| Fabrizio De Mattia | |||
| Jean-Michel Chapsal | |||
| Imke Kross | |||
| Cecile Ponsar | |||
| Frederic Mortiaux | |||
| Jo McKelvie | |||
| Johan Descamps | |||
| Nicholas Jarrett | |||
| P433 | issue | 1 | |
| P304 | page(s) | 59-65 | |
| P577 | publication date | 2011-01-31 | |
| P1433 | published in | Biologicals | Q4915041 |
| P1476 | title | The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs | |
| P478 | volume | 39 |
| Q40632686 | A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine |
| Q94662620 | A novel electrophoretic immunoblot as antigen desorption and quantification method for alum-adjuvanted veterinary rabies vaccines |
| Q41121931 | A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine |
| Q44504915 | Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production |
| Q35884865 | Bridging the Gap Between Validation and Implementation of Non-Animal Veterinary Vaccine Potency Testing Methods |
| Q97522644 | Formaldehyde treatment of proteins enhances proteolytic degradation by the endo-lysosomal protease cathepsin S |
| Q60310521 | Identity, Structure and Compositional Analysis of Aluminum Phosphate Adsorbed Pediatric Quadrivalent and Pentavalent Vaccines |
| Q91594094 | Incidental induction of secondary bowel disorders in guinea pigs during a batch safety test of veterinary vaccines |
| Q93192113 | Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations |
| Q91911903 | Non-animal replacement methods for human vaccine potency testing: state of the science and future directions |
| Q90886705 | One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective |
| Q57483923 | Raman spectroscopy-based identification of toxoid vaccine products |
| Q35895817 | The importance of animal models in tuberculosis vaccine development. |
Search more.